AI assistant
Sending…
PRECIGEN, INC. — Director's Dealing 2020
Oct 9, 2020
32044_dirs_2020-10-09_e4a6bed3-2333-4963-94a6-df83094e4e88.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PRECIGEN, INC. (PGEN)
CIK: 0001356090
Period of Report: 2020-10-07
Reporting Person: Ares Trading S.A. (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-10-07 | Common Stock | P | 6758400 | $3.6991 | Acquired | 27398519 | Direct |
Footnotes
F1: On October 7, 2020, Ares Trading S.A. converted all of the $25,000,000 outstanding principal amount of the Convertible Note issued to Ares Trading S.A. (as described in Footnote (1) to the Form 3 filed by the reporting persons on January 22, 2019) into 6,758,400 shares of Common Stock of the Issuer at a conversion price of $3.6991 per share, reflecting the volume weighted-average price per share of the Common Stock on the Nasdaq Stock Market for the consecutive ten trading days immediately prior to the conversion date.
More from PRECIGEN, INC.
Regulatory Filings
2026
May 13
Annual Report
2026
Apr 30
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Jan 23
Director's Dealing
2025
Dec 23